Who is sponsoring NCT04816110?

NCT04816110 is sponsored by Alexandria University.

What drugs are being tested in NCT04816110?

Interventions in NCT04816110: mineralized plasmatic matrix with collagen membrane, mineralized plasmatic matrix (MPM) without collagen membrane.

What condition does NCT04816110 study?

NCT04816110 studies Horizontal Alveolar Bone Defect, Alveolar Bone Loss.

Is NCT04816110 still recruiting?

NCT04816110 is currently completed. Last updated 25 March 2021.

Last reviewed 2021-03-25 · How we verify

NCT04816110

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Mineralized Plasmatic Matrix With and Without Collagen Membrane in Peri-implant Bone Regeneration

Completed Phase 2 Last updated 25 March 2021

What this trial tests

Phase 2 trial testing mineralized plasmatic matrix with collagen membrane in Horizontal Alveolar Bone Defect in 16 participants. Completed in 15 December 2020.

Timeline

10 April 2019

Primary endpoint
10 September 2020

15 December 2020

Quick facts

Lead sponsor	Alexandria University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	16
Start date	10 April 2019
Primary completion	10 September 2020
Estimated completion	15 December 2020
Sites	1 location across Egypt

Drugs / interventions tested

mineralized plasmatic matrix with collagen membrane — full drug profile →
mineralized plasmatic matrix (MPM) without collagen membrane — full drug profile →

Conditions studied

Horizontal Alveolar Bone Defect — all drugs for Horizontal Alveolar Bone Defect →
Alveolar Bone Loss — all drugs for Alveolar Bone Loss →

Sponsor

Alexandria University

Who can join

Adults 20 to 40, any sex, with Horizontal Alveolar Bone Defect or Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study focuses on comparing the effect of MPM with or without collagen membrane on delayed implant placement in anterior maxillary aesthetic zone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Alexandria University trials

Trials by the same sponsor.

NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04816110 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexandria University
Last refreshed: 25 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04816110.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing